Baxter International Inc. BAX

Revenue Intelligence Report • 70 quarters of SEC filing data • Updated 2026-03-15

Baxter International Inc. has a forecasted full-year revenue of $12B, a +7.8% year-over-year change, based on 70 quarters of SEC filing data. Key revenue drivers include R&D ($5.08 per $1) and SG&A ($1.88 per $1). The ARDL model has 5.6% MAPE.

Investment Thesis

The econometric model achieves strong accuracy (5.6% MAPE), suggesting Baxter International Inc.'s revenue trajectory is well-characterized by its spending patterns. Every $1 of R&D investment is associated with $5.08 of revenue, indicating efficient capital deployment in innovation. Each $1 of SG&A spending generates $1.88 in revenue, reflecting strong commercial efficiency.

Next FY Revenue
$12.1B
+7.8% YoY
R&D Multiplier
$5.08 per $1
SG&A Multiplier
$1.88 per $1
Model Accuracy
5.6% MAPE
Holdout validation: The model predicted $2.9B vs the actual $3.0B — an error of 3.0%.

Revenue Forecast

BAX Revenue Forecast

Quarterly Detail

QuarterModel ForecastActual95% RangeYoY GrowthStatus
Q4 2025 $2.9B $3.0B $2.5B – $3.3B +4.8% ✓ In range
Q2 2026 $2.9B $2.4B – $3.5B +12.2%
Q3 2026 $3.0B $2.3B – $3.7B +7.0%
Q4 2026 $3.1B $2.3B – $3.9B +7.7%
Q1 2027 $3.1B $2.2B – $4.0B +4.8%

Seasonal Factors

Multiplicative seasonal adjustment: These factors capture Baxter International Inc.'s systematic quarterly revenue patterns relative to the trend model. A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below. Factors are computed as the median of (actual / fitted) across all available quarters.
Fiscal QuarterSeasonal Factorvs TrendInterpretationObs.
FQ1 (Sep–Nov) 1.0183 +1.8% In line with trend 17
FQ2 (Dec–Feb) 1.0169 +1.7% In line with trend 17
FQ3 (Mar–May) 0.9154 -8.5% -8.5% below trend 16
FQ4 (Jun–Aug) 1.029 +2.9% In line with trend 16

How Spending Drives Revenue

BAX Spending Timing
Reading this chart: Each line shows the cumulative revenue generated per $1 spent over subsequent quarters. The effect builds over 4-5 quarters as investments mature.

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch

More in Healthcare

INCY CRL WAT BDX ABBV PODD HSIC KVUE